期刊文献+

伴2型糖尿病的老年男性部分雄激素缺乏综合征与骨质疏松的关系 被引量:1

Relationship between partial androgen deficiency syndrome with type 2 diabetes mellitus and osteoporosis in the aging male
下载PDF
导出
摘要 目的:探讨伴有2型糖尿病的老年男性部分雄激素缺乏综合征(partialandrogendeficiencysynsdromeintheagingmales,PADAM)患者与骨质疏松的关系。方法:PADAM患者35例,伴2型糖尿病的PADAM患者36例,均采用放射免疫法测定游离睾酮(FT),定量CT测定骨密度(BMD),同时测定空腹和餐后2h血糖及糖化血红蛋白。结果:伴有2型糖尿病的PADAM组FT水平和BMD低于PADAM组,后者又低于对照组(P<0.001)。结论:PADAM是骨质疏松发生的重要原因,若伴有糖尿病将加重骨质疏松的程度。 AIM:To discuss the association between partial androgen deficiency syndrome in the aging males(PADAM) with type 2 diabetes mellitus(DM) and osteoporosis. METHODS:Bone mineral density(BMD) was determined by quantitative CT,and free testosterone(FT) was mensurated by radioimmunoassay,and meanwhile,fasting plasma glucose(FBG),2 hour postprandial plasma glucose and HbA1C were determined for 35 PADAM patients and 36 PADAM patients with type 2 DM. RESULTS:The levels of FT and BMD in PADAM with type 2 DM group were lower than those of PADAM group,which were lower in the latter group as compared with the control group(P< 0.001). CONCLUSION:PADAM is one of the important reasons for the occurrence of osteoporosis,and the degree of osteoporosis is aggravated if with type 2 DM.
出处 《中国临床康复》 CSCD 2004年第21期4312-4313,共2页 Chinese Journal of Clinical Rehabilitation
  • 相关文献

参考文献10

二级参考文献19

  • 1郁任杰.杞菊地黄汤加减治疗男性更年期综合征[J].内蒙古中医药,1998,17(1):17-17.
  • 2许晓 张新安.二仙汤为主治疗男性更年期综合征21例[J].福建中医药,1997,28(6):51-51.
  • 3何俊清.六味地黄汤加减治疗男性更年期综合征[J].湖北中医杂志,1997,19(6):5-5.
  • 4Eastell R, Reid DM, Compston J, et al. A UK consensus group on management of glucoeorticoid-induced osteoporosis.J Intern Meal, 1998, 244:271-292.
  • 5Ishida Y, Heersche JNM. Glucocorticoid-induced osteoporosis:both in vivo and in vitro concentrations of glucoeorticoids higher than physiological levels attenuate osteoblast differentiation. J Bone Min Res, 1998, 13:1822-1826.
  • 6Hofbauer LC, Khosla S, Dunstan CR, et al. The roles of osteoporotegrin and osteoprotegerin ligand in the paraerine regulation of bone resorption. J Bone Min Res, 2000, 15:2-12.
  • 7Cooper MS, Walker EA, Bland R, et al. Expression and functional consequences of 11 beta-hydroxysteroid dehydrogenase activity in human bone. Bone, 2000, 270):375-381.
  • 8Bilezikian JP, Morishima A, Ben J, et al. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med, 1998, 339:599-603.
  • 9Writing group for the Women's Health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Results from the Women's Health Initiative randomized controlled trial. JAMA, 2002,288:321-333.
  • 10Peach K. Differential ligand activation of estrogen receptors Erα and Erβ at AP1 site. Science, 1997, 277:1508-1510.

共引文献39

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部